210
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2026
Study Completion Date
April 1, 2027
xDRIVE Tumor Profiling
Patients and physicians will receive tumor profiling data via xDRIVE Functional Precision Medicine and Artificial Intelligence analysis. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment.
First Ascent Biomedical Inc.
INDUSTRY